Roche Sets Groundwork For Rapid Expansion In China Through R&D Partnerships
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Roche is laying the groundwork for a major new phase in expansion across China through partnerships with promising pharmaceutical research outfits and biotechnology start-ups, according to senior Roche executives
You may also be interested in...
Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 1 of 2)
Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.
Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 1 of 2)
Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.
Roche Seeks Partnerships, Innovation In China Rather Than Outsourcing
Novel targets that are best and first in class with solid IP and potential to change standard of care qualify as partnering opportunities.